179 related articles for article (PubMed ID: 20229045)
1. Evaluation of a CXCR4 antagonist in a xenograft mouse model of inflammatory breast cancer.
Singh B; Cook KR; Martin C; Huang EH; Mosalpuria K; Krishnamurthy S; Cristofanilli M; Lucci A
Clin Exp Metastasis; 2010 Apr; 27(4):233-40. PubMed ID: 20229045
[TBL] [Abstract][Full Text] [Related]
2. A CXCR4 antagonist CTCE-9908 inhibits primary tumor growth and metastasis of breast cancer.
Huang EH; Singh B; Cristofanilli M; Gelovani J; Wei C; Vincent L; Cook KR; Lucci A
J Surg Res; 2009 Aug; 155(2):231-6. PubMed ID: 19482312
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of CXCR4 by CTCE-9908 inhibits breast cancer metastasis to lung and bone.
Richert MM; Vaidya KS; Mills CN; Wong D; Korz W; Hurst DR; Welch DR
Oncol Rep; 2009 Mar; 21(3):761-7. PubMed ID: 19212637
[TBL] [Abstract][Full Text] [Related]
4. CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model.
Hassan S; Buchanan M; Jahan K; Aguilar-Mahecha A; Gaboury L; Muller WJ; Alsawafi Y; Mourskaia AA; Siegel PM; Salvucci O; Basik M
Int J Cancer; 2011 Jul; 129(1):225-32. PubMed ID: 20830712
[TBL] [Abstract][Full Text] [Related]
5. Effective inhibition of metastases and primary tumor growth with CTCE-9908 in esophageal cancer.
Drenckhan A; Kurschat N; Dohrmann T; Raabe N; Koenig AM; Reichelt U; Kaifi JT; Izbicki JR; Gros SJ
J Surg Res; 2013 Jun; 182(2):250-6. PubMed ID: 23117118
[TBL] [Abstract][Full Text] [Related]
6. Treatment of experimental human breast cancer and lung cancer brain metastases in mice by macitentan, a dual antagonist of endothelin receptors, combined with paclitaxel.
Lee HJ; Hanibuchi M; Kim SJ; Yu H; Kim MS; He J; Langley RR; Lehembre F; Regenass U; Fidler IJ
Neuro Oncol; 2016 Apr; 18(4):486-96. PubMed ID: 26995790
[TBL] [Abstract][Full Text] [Related]
7. Sensitization of B16 tumor cells with a CXCR4 antagonist increases the efficacy of immunotherapy for established lung metastases.
Lee CH; Kakinuma T; Wang J; Zhang H; Palmer DC; Restifo NP; Hwang ST
Mol Cancer Ther; 2006 Oct; 5(10):2592-9. PubMed ID: 17041104
[TBL] [Abstract][Full Text] [Related]
8. Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivo detection of mammary tumors and multiple metastases in immune deficient mice.
Jenkins DE; Hornig YS; Oei Y; Dusich J; Purchio T
Breast Cancer Res; 2005; 7(4):R444-54. PubMed ID: 15987449
[TBL] [Abstract][Full Text] [Related]
9. Targeting CXCR4 by a selective peptide antagonist modulates tumor microenvironment and microglia reactivity in a human glioblastoma model.
Mercurio L; Ajmone-Cat MA; Cecchetti S; Ricci A; Bozzuto G; Molinari A; Manni I; Pollo B; Scala S; Carpinelli G; Minghetti L
J Exp Clin Cancer Res; 2016 Mar; 35():55. PubMed ID: 27015814
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases.
Kim SY; Lee CH; Midura BV; Yeung C; Mendoza A; Hong SH; Ren L; Wong D; Korz W; Merzouk A; Salari H; Zhang H; Hwang ST; Khanna C; Helman LJ
Clin Exp Metastasis; 2008; 25(3):201-11. PubMed ID: 18071913
[TBL] [Abstract][Full Text] [Related]
11. CXCR4 antagonists suppress small cell lung cancer progression.
Taromi S; Kayser G; Catusse J; von Elverfeldt D; Reichardt W; Braun F; Weber WA; Zeiser R; Burger M
Oncotarget; 2016 Dec; 7(51):85185-85195. PubMed ID: 27835905
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo therapeutic efficacy of CXCR4 antagonist BKT140 against human non-small cell lung cancer.
Fahham D; Weiss ID; Abraham M; Beider K; Hanna W; Shlomai Z; Eizenberg O; Zamir G; Izhar U; Shapira OM; Peled A; Wald O
J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1167-1175.e1. PubMed ID: 22925564
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4.
Liang Z; Wu T; Lou H; Yu X; Taichman RS; Lau SK; Nie S; Umbreit J; Shim H
Cancer Res; 2004 Jun; 64(12):4302-8. PubMed ID: 15205345
[TBL] [Abstract][Full Text] [Related]
14. Targeting CXCR4 with CTCE-9908 inhibits prostate tumor metastasis.
Wong D; Kandagatla P; Korz W; Chinni SR
BMC Urol; 2014 Jan; 14():12. PubMed ID: 24472670
[TBL] [Abstract][Full Text] [Related]
15. Effects of CXCR4 antagonist CTCE-9908 on prostate tumor growth.
Porvasnik S; Sakamoto N; Kusmartsev S; Eruslanov E; Kim WJ; Cao W; Urbanek C; Wong D; Goodison S; Rosser CJ
Prostate; 2009 Sep; 69(13):1460-9. PubMed ID: 19588526
[TBL] [Abstract][Full Text] [Related]
16. CXCR4 regulates growth of both primary and metastatic breast cancer.
Smith MC; Luker KE; Garbow JR; Prior JL; Jackson E; Piwnica-Worms D; Luker GD
Cancer Res; 2004 Dec; 64(23):8604-12. PubMed ID: 15574767
[TBL] [Abstract][Full Text] [Related]
17. Bifunctional fused polypeptide inhibits the growth and metastasis of breast cancer.
Liang AL; Qian HL; Zhang TT; Zhou N; Wang HJ; Men XT; Qi W; Zhang PP; Fu M; Liang X; Lin C; Liu YJ
Drug Des Devel Ther; 2015; 9():5671-86. PubMed ID: 26527862
[TBL] [Abstract][Full Text] [Related]
18. Development of a unique small molecule modulator of CXCR4.
Liang Z; Zhan W; Zhu A; Yoon Y; Lin S; Sasaki M; Klapproth JM; Yang H; Grossniklaus HE; Xu J; Rojas M; Voll RJ; Goodman MM; Arrendale RF; Liu J; Yun CC; Snyder JP; Liotta DC; Shim H
PLoS One; 2012; 7(4):e34038. PubMed ID: 22485156
[TBL] [Abstract][Full Text] [Related]
19. Synergistic inhibitory activity of zoledronate and paclitaxel on bone metastasis in nude mice.
Lu S; Zhang J; Zhou Z; Liao ML; He WZ; Zhou XY; Li ZM; Xiang JQ; Wang JJ; Chen HQ
Oncol Rep; 2008 Sep; 20(3):581-7. PubMed ID: 18695909
[TBL] [Abstract][Full Text] [Related]
20. [Chemokine receptor CXCR4 gene silencing with shRNA inhibits breast cancer metastasis to the lung in nude mice].
Zhang MX; Han N; Yu SY; Leng Y
Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):325-9. PubMed ID: 18953828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
